The partnership with Beckman Coulter Life Sciences is likely to be seen as a positive development for Telesis Bio Partners, as it could lead to advancements in their technology and potentially increase their market share in the biotech industry. This news has already resulted in a rise in TBIO's stock price, indicating investor optimism.